A study found a loss-of-function variant in EFCAB12 in a patient with unilateral kidney anomaly, and a number of extrarenal symptoms, such as neurodevelopmental delay, epilepsy, and corpus callosum20. Here, EFCAB12 is linked to epilepsy.